Outpatients with calcidiol of 20-30 ng/ml (50-75 nmol/l) had a higher number of comorbidities compared to those with 30-50 ng/ml (75-150 nmol/l). Suggests the frequently used cut-off of 50 nmol/l is too low. https://t.co/Al9DCpuxq2
RT @iofbonehealth: #Osteoporosis Int: Study shows Patients with serum #VitaminD 25OHD ≥ 20 & < 30 ng/mL had higher prevalence of comorbidit…
RT @doctorneyro: #Patients with serum #25OHvitaminaD ≥ 20 and < 30 ng/mL had higher prevalence of #comorbidities compared to ≥ 30 ng/mL.#as…
RT @Osteoporosis_NL: Outpatients tertiary hospital with serum 25OHD ≥ 20 and < 30 ng/mL had more comorbidities compared to ≥ 30 ng/mL (Bra…
RT @Osteoporosis_NL: Outpatients tertiary hospital with serum 25OHD ≥ 20 and < 30 ng/mL had more comorbidities compared to ≥ 30 ng/mL (Bra…
Outpatients tertiary hospital with serum 25OHD ≥ 20 and < 30 ng/mL had more comorbidities compared to ≥ 30 ng/mL (Brazil) https://t.co/z5IEtc3mY2
RT @iofbonehealth: #Osteoporosis Int: Study shows Patients with serum #VitaminD 25OHD ≥ 20 & < 30 ng/mL had higher prevalence of comorbidit…
RT @iofbonehealth: #Osteoporosis Int: Study shows Patients with serum #VitaminD 25OHD ≥ 20 & < 30 ng/mL had higher prevalence of comorbidit…
RT @iofbonehealth: #Osteoporosis Int: Study shows Patients with serum #VitaminD 25OHD ≥ 20 & < 30 ng/mL had higher prevalence of comorbidit…
RT @iofbonehealth: #Osteoporosis Int: Study shows Patients with serum #VitaminD 25OHD ≥ 20 & < 30 ng/mL had higher prevalence of comorbidit…
RT @doctorneyro: #Patients with serum #25OHvitaminaD ≥ 20 and < 30 ng/mL had higher prevalence of #comorbidities compared to ≥ 30 ng/mL.#as…
RT @doctorneyro: #Patients with serum #25OHvitaminaD ≥ 20 and < 30 ng/mL had higher prevalence of #comorbidities compared to ≥ 30 ng/mL.#as…
RT @doctorneyro: #Patients with serum #25OHvitaminaD ≥ 20 and < 30 ng/mL had higher prevalence of #comorbidities compared to ≥ 30 ng/mL.#as…
#Osteoporosis Int: Study shows Patients with serum #VitaminD 25OHD ≥ 20 & < 30 ng/mL had higher prevalence of comorbidities compared to ≥ 30 ng/mL. https://t.co/pt6M7hVBIC https://t.co/NQh2HBOTqy
#Patients with serum #25OHvitaminaD ≥ 20 and < 30 ng/mL had higher prevalence of #comorbidities compared to ≥ 30 ng/mL.#asistenciasanitaria. #osteoporosis #vitaminaD #saludelamujer https://t.co/u0bquvuFdv https://t.co/8wf0aLTy9g